Cardiometabolic Precision Medicine Program

Cardiometabolic Precision Medicine is a new program at Columbia University Irving Medical Center and NewYork-Presbyterian as of 2017. The purpose of the program is to leverage precision medicine to enable healthier lives, free of cardiovascular disease and related metabolic disorders. This one-of-a-kind program is comprised of five components:

These cross-cutting components represent physicians, scientists, and medical researchers from various disciplines including cardiology, metabolism and biology, bioinformatics, and beyond. The vision for our Cardiogenetics Clinic is to provide patients with a comprehensive service to analyze their genomes and “omics”, which will be used in determining their care. Research involving patients will focus on discovery of new disease-causing mutations and genomic contribution to disease. Basic science research laboratories will work on the mutations and variations found in these patients, including the development of translational therapeutics. Novel diagnostic treatments can then be brought to the patients that have been characterized. The data generated from each of these steps will be immensely important to the future of all cardiovascular and metabolic medicine and the Columbia University Precision Medicine Initiative.


2 females discussing while sitting at a conference table